Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy

    Pfizer 's CEO said the company is not in talks with China to license a generic version of its Covid-19 pill, Paxlovid, for use there.
    by Ed Silverman Jan 11, 2023 1 minute
    Source: Alex Hogan/STAT

    Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Pfizer’s DTC Platform, Sandoz’s Feud With A U.K. Trade Group, And More
    Pfizer filed a trademark application last month for a website and app providing medical information and mail-order pharmacy and telehealth services to U.S. patients.
    STAT1 min read
    STAT+: Microsoft’s Peter Lee Says ChatGPT Shouldn’t Be Used For Initial Diagnosis
    Speaking at #STATBreakthrough Summit, Microsoft’s Peter Lee talked about how ChatGPT and generative AI still have tricky blindspots.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks